Monoclonal antibody produced by myeloma-spleen cell hybrid has been one among other important tools in many biological research as well as in their practical use. Technological advancement related to hybridoma construction and growth is therefore one among other interesting subject to be further explored. In this communication, recent findings related to above mentioned will be reviewed.